Point72 Asset Management L.P. Invests $88,000 in National Research Co. (NASDAQ:NRC)

Point72 Asset Management L.P. bought a new stake in National Research Co. (NASDAQ:NRC) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,857 shares of the company’s stock, valued at approximately $88,000.

Several other large investors have also recently bought and sold shares of NRC. Algert Global LLC grew its stake in National Research by 94.0% in the third quarter. Algert Global LLC now owns 82,921 shares of the company’s stock valued at $1,896,000 after purchasing an additional 40,182 shares in the last quarter. Renaissance Technologies LLC lifted its position in shares of National Research by 14.4% in the second quarter. Renaissance Technologies LLC now owns 432,884 shares of the company’s stock worth $9,935,000 after buying an additional 54,600 shares during the last quarter. Marshall Wace LLP bought a new stake in shares of National Research during the 2nd quarter worth about $1,644,000. Millennium Management LLC raised its stake in shares of National Research by 200.9% in the 2nd quarter. Millennium Management LLC now owns 214,858 shares of the company’s stock valued at $4,931,000 after acquiring an additional 143,454 shares in the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC raised its position in shares of National Research by 0.6% in the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 3,045,306 shares of the company’s stock valued at $69,890,000 after purchasing an additional 18,891 shares during the period. 47.26% of the stock is owned by institutional investors and hedge funds.

National Research Stock Performance

Shares of NRC opened at $17.79 on Friday. The company has a market capitalization of $417.64 million, a PE ratio of 15.74 and a beta of 0.52. The company has a debt-to-equity ratio of 1.30, a current ratio of 0.47 and a quick ratio of 0.47. National Research Co. has a one year low of $17.62 and a one year high of $42.18. The company’s fifty day moving average price is $19.16 and its 200 day moving average price is $21.90.

National Research (NASDAQ:NRC) last released its earnings results on Friday, October 25th. The company reported $0.24 earnings per share (EPS) for the quarter. National Research had a return on equity of 67.40% and a net margin of 18.78%. The firm had revenue of $35.82 million for the quarter.

National Research Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Friday, December 27th will be issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 2.70%. The ex-dividend date of this dividend is Friday, December 27th. National Research’s payout ratio is presently 42.48%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.